© Khunaspix Dreamstime.
CNBC reports:
– Dr. Albert Bourla, chairman and CEO of Pfizer, hailed the trial results as a “great day for science and humanity.”
– Pfizer and BioNTech said the case split between vaccinated individuals and those who received a placebo indicated a vaccine efficacy rate of above 90% at seven days after the second dose.
– It means that protection from Covid-19 is achieved 28 days after the initial vaccination, which consists of a two-dose schedule.
U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial.
It comes as drugmakers and research centers around the world scramble to deliver a safe and effective vaccine in an attempt to bring an end to the coronavirus pandemic that has claimed over 1.25 million lives worldwide.
Scientists are hoping for a coronavirus vaccine that is at least 75% effective, while White House coronavirus advisor Dr. Anthony Fauci has previously said one that is 50% or 60% effective would be acceptable.
To read the full post, please click here.
REACTION
– Pre-market reaction: “Stock futures surge, with Dow futures up 1400 points, after Pfizer vaccine trial. Pfizer CEO: ‘Today is a great day for science and humanity.’”
– More here: “S&P futures, global stocks soar to all time high, Russell limit up on Covid vaccine news“.
– Early pre-market (pre-vaccine) trade: “Risk assets jump as traders put money to work“.
– Wall Street Breakfast: “Post-election rally continues“.
– Brent up a lot. Gold under pressure.
– Rates soar closer to 1%…
– VIX down to 23.50 (-14.7%) @ 1.48pm GMT.
Comment on this article